Emageon elects French to Board

TriMed Staff | | Health Imaging | Artificial Intelligence
Emageon elected Douglas D. French to its Board of Directors, which makes the company’s ninth board appointment. French is principal and founder of JD Resources, LLC, a healthcare advisory firm in St. Louis, Mo. Before founding JD Resources, he served from 2001 to 2004 as president and CEO of Ascension Health, the largest not-for-profit hospital network in the United States.

TriMed Staff

Related Content

GBCA dose reduced by up to 80% with help from deep learning-based image reconstruction
Deep learning-based reconstruction nearly halves spinal MRI acquisition times
Experts highlight 'significant concerns' with fluctuating accuracy of popular large language models
FDA clears AI screening tool for cardiac amyloidosis
Are providers too trusting of AI's advice?
Pairing an alert system with CAD software halves time-to-treatment for pneumothorax

Around the web

Cardiovascular Business
Positron partners with Upbeat Cardiology Solutions to improve cardiac PET/CT access

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.